Design of selective phenylglycine amide tissue factor/factor VIIa inhibitors
Proof of concept experiments have shown that tissue factor/factor VIIa inhibitors have antithrombotic activity without enhancing bleeding propensity. Starting from lead compounds generated by a biased combinatorial approach, phenylglycine amide tissue fac
Groebke Zbinden, Katrin,Banner, David W.,Ackermann, Jean,D'Arcy, Allan,Kirchhofer, Daniel,Ji, Yu-Hua,Tschopp, Thomas B.,Wallbaum, Sabine,Weber, Lutz
p. 817 - 822
(2007/10/03)
More Articles about upstream products of 227023-69-0
Get Best Price for227023-69-0{2-(2-benzenesulfonylamino-4-benzyloxy-5-methoxy-phenyl)-2-[4-(N-hydroxycarbamimidoyl)-phenylamino]-acetylamino}-phenyl-acetic acid